Hypertension is highly prevalent in patients with diabetic nephropathy. Diabetic nephropathy
is the leading cause of CKD and end-stage kidney disease in the United States. The …

We report an improved draft nucleotide sequence of the 2.3-gigabase genome of maize, an
important crop plant and model for biological research. Over 32,000 genes were predicted, …

… Peter Van Buren Peter Van Buren … As sarcomere length increases, the slope increases most
rapidly in the HTN(+)HFpEF group (P<0.0001 in comparison with both the control and HTN[–…

Background: Intradialytic hypertension is a condition where there is an increase in blood
pressure (BP) from pre- to post-hemodialysis; this condition has been recently identified as an …

… Dr Van Buren reports receipt of grant support from NIH and personal fees for consultancy
services from Medtronic. Dr Anstrom reports receipt of grant support from the Heart Failure …

Hypertension is a comorbidity that is present in the majority of end‐stage renal disease
patients on maintenance hemodialysis. This population is particularly unique because of the …

Objectives : The primary objective of the study was a change in left ventricular end-systolic
volume index (LVESVi) from baseline to 6 months of spinal cord stimulation (SCS) therapy in …

The focus of this paper, which is based on a reading of investigations into attrition reported
in the literature, will be theoretical. It will consider the relevance of recent ideas in the …

… The primary outcome variable was the mean 44-hour ambulatory systolic BP, which was
analyzed between groups with a two-sided unpaired t test, using a P value of 0.05 to determine …

Results Flow-mediated vasodilation was significantly improved with carvedilol (from 1.03%
to 1.40%, P= 0.02). There was no significant change in endothelial progenitor cells, …